406 related articles for article (PubMed ID: 33658779)
1. Progress of Nanotechnology in Diabetic Retinopathy Treatment.
Liu Y; Wu N
Int J Nanomedicine; 2021; 16():1391-1403. PubMed ID: 33658779
[TBL] [Abstract][Full Text] [Related]
2. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.
Royle P; Mistry H; Auguste P; Shyangdan D; Freeman K; Lois N; Waugh N
Health Technol Assess; 2015 Jul; 19(51):v-xxviii, 1-247. PubMed ID: 26173799
[TBL] [Abstract][Full Text] [Related]
3. Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT.
Lois N; Campbell C; Waugh N; Azuara-Blanco A; Maredza M; Mistry H; McAuley D; Acharya N; Aslam TM; Bailey C; Chong V; Downey L; Eleftheriadis H; Fatum S; George S; Ghanchi F; Groppe M; Hamilton R; Menon G; Saad A; Sivaprasad S; Shiew M; Steel DH; Talks JS; Doherty P; McDowell C; Clarke M
Health Technol Assess; 2022 Dec; 26(50):1-86. PubMed ID: 36541393
[TBL] [Abstract][Full Text] [Related]
4. Laser photocoagulation for proliferative diabetic retinopathy.
Evans JR; Michelessi M; Virgili G
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD011234. PubMed ID: 25420029
[TBL] [Abstract][Full Text] [Related]
5. The role of vitrectomy for diabetic retinopathy.
Arrigg PG; Cavallerano J
J Am Optom Assoc; 1998 Nov; 69(11):733-40. PubMed ID: 9844325
[TBL] [Abstract][Full Text] [Related]
6. [Angiopathy and the eye].
Rencová E
Vnitr Lek; 2010 Apr; 56(4):333-9. PubMed ID: 20465107
[TBL] [Abstract][Full Text] [Related]
7. Management of diabetic retinopathy: a systematic review.
Mohamed Q; Gillies MC; Wong TY
JAMA; 2007 Aug; 298(8):902-16. PubMed ID: 17712074
[TBL] [Abstract][Full Text] [Related]
8. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy.
Martinez-Zapata MJ; Martí-Carvajal AJ; Solà I; Pijoán JI; Buil-Calvo JA; Cordero JA; Evans JR
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD008721. PubMed ID: 25418485
[TBL] [Abstract][Full Text] [Related]
9. Evidence-Based Treatment of Diabetic Retinopathy.
El Rami H; Barham R; Sun JK; Silva PS
Semin Ophthalmol; 2017; 32(1):67-74. PubMed ID: 27700224
[TBL] [Abstract][Full Text] [Related]
10. Surgical Innovations in the Treatment of Diabetic Macular Edema and Diabetic Retinopathy.
Berrocal MH; Acaba LA; Chenworth ML
Curr Diab Rep; 2019 Sep; 19(10):106. PubMed ID: 31529405
[TBL] [Abstract][Full Text] [Related]
11. Management of Complications and Vision Loss from Proliferative Diabetic Retinopathy.
Crabtree GS; Chang JS
Curr Diab Rep; 2021 Sep; 21(9):33. PubMed ID: 34477996
[TBL] [Abstract][Full Text] [Related]
12. The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema.
Do DV; Schmidt-Erfurth U; Gonzalez VH; Gordon CM; Tolentino M; Berliner AJ; Vitti R; Rückert R; Sandbrink R; Stein D; Yang K; Beckmann K; Heier JS
Ophthalmology; 2011 Sep; 118(9):1819-26. PubMed ID: 21546089
[TBL] [Abstract][Full Text] [Related]
13. [Modern approach to early diagnosis and pathogenetic treatment of diabetic retinopathy].
Vorob'eva IV
Vestn Oftalmol; 2016; 132(5):60-67. PubMed ID: 27911427
[TBL] [Abstract][Full Text] [Related]
14. Management of proliferative diabetic retinopathy.
Gündüz K; Bakri SJ
Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
[TBL] [Abstract][Full Text] [Related]
15. [Diabetic retinopathy].
Barth T; Helbig H
Klin Monbl Augenheilkd; 2021 Oct; 238(10):1143-1159. PubMed ID: 34380155
[TBL] [Abstract][Full Text] [Related]
16. The Evolving Treatment of Diabetic Retinopathy.
Mansour SE; Browning DJ; Wong K; Flynn HW; Bhavsar AR
Clin Ophthalmol; 2020; 14():653-678. PubMed ID: 32184554
[TBL] [Abstract][Full Text] [Related]
17. Current Approaches in Treatment of Diabetic Retinopathy and Future Perspectives.
Kutlutürk Karagöz I; Allahverdiyev A; Bağırova M; Abamor EŞ; Dinparvar S
J Ocul Pharmacol Ther; 2020 Sep; 36(7):487-496. PubMed ID: 32453671
[TBL] [Abstract][Full Text] [Related]
18. Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.
Smith JM; Steel DH
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD008214. PubMed ID: 26250103
[TBL] [Abstract][Full Text] [Related]
19. Early pars plana vitrectomy for proliferative diabetic retinopathy: update and review of current literature.
Berrocal MH; Acaba-Berrocal L
Curr Opin Ophthalmol; 2021 May; 32(3):203-208. PubMed ID: 33770016
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in intraocular and novel drug delivery systems for the treatment of diabetic retinopathy.
Sharma DS; Wadhwa S; Gulati M; Kadukkattil Ramanunny A; Awasthi A; Singh SK; Khursheed R; Corrie L; Chitranshi N; Gupta VK; Vishwas S
Expert Opin Drug Deliv; 2021 May; 18(5):553-576. PubMed ID: 33143473
[No Abstract] [Full Text] [Related]
[Next] [New Search]
